As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 1/17/24  NeuBase Therapeutics, Inc.        8-K:5       1/12/24   10:184K                                   Toppan Merrill/FA        
 7/31/23  NeuBase Therapeutics, Inc.        8-K:5,9     7/28/23   11:178K                                   Toppan Merrill Bridge/FA 
 5/18/23  NeuBase Therapeutics, Inc.        8-K:5       5/12/23   10:149K                                   Toppan Merrill Bridge/FA 
10/24/22  NeuBase Therapeutics, Inc.        8-K:5      10/18/22   10:185K                                   Toppan Merrill/FA        
10/14/22  NeuBase Therapeutics, Inc.        8-K:2,5,8,9 10/7/22   11:214K                                   Toppan Merrill/FA        
 6/29/22  NeuBase Therapeutics, Inc.        8-K:5,8,9   6/23/22   11:206K                                   Toppan Merrill/FA        
 1/10/22  NeuBase Therapeutics, Inc.        8-K:5,8,9   1/10/22   12:266K                                   Toppan Merrill/FA        
  1/5/22  NeuBase Therapeutics, Inc.        8-K:5,8,9    1/1/22   11:215K                                   Toppan Merrill/FA        
10/22/21  NeuBase Therapeutics, Inc.        8-K:5      10/22/21   10:186K                                   Toppan Merrill/FA        
 10/1/21  NeuBase Therapeutics, Inc.        8-K:5,9     9/30/21   11:233K                                   Toppan Merrill/FA        
 8/12/21  NeuBase Therapeutics, Inc.        8-K:2,5,9   8/10/21    2:44K                                    Toppan Merrill/FA        
 5/25/21  NeuBase Therapeutics, Inc.        8-K:5,8,9   5/25/21    3:76K                                    Toppan Merrill/FA        
 5/20/21  NeuBase Therapeutics, Inc.        8-K:5,8,9   5/17/21    3:86K                                    Toppan Merrill/FA        
 5/12/21  NeuBase Therapeutics, Inc.        8-K:5,8,9   5/11/21    2:39K                                    Toppan Merrill/FA        
 3/26/21  NeuBase Therapeutics, Inc.        8-K:5       3/25/21    1:17K                                    Toppan Merrill/FA        
 12/2/20  NeuBase Therapeutics, Inc.        8-K:5,8,9  11/30/20    3:76K                                    Toppan Merrill/FA        
 7/28/20  NeuBase Therapeutics, Inc.        8-K:5,8,9   7/22/20    3:80K                                    Toppan Merrill/FA        
 7/17/19  NeuBase Therapeutics, Inc.        8-K/A:3,5,9 7/12/19    2:88K                                    Quality EDGAR So… LLC/FA 
 7/12/19  NeuBase Therapeutics, Inc.        8-K:1,2,3,5 7/12/19    5:522K                                   Quality EDGAR So… LLC/FA 
  1/3/19  NeuBase Therapeutics, Inc.        8-K:1,2,5,7  1/2/19    8:7.3M                                   Quality EDGAR So… LLC/FA 

____________
¹	Filing/Form Type:  -K
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.